Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000391635

Medchemexpress LLC Yl-5092 | 3056857-07-6 | 99.83% | 441.43 | 50 MG
SDP

Catalog No. 5000391635
Encompass_Preferred

YL-5092 is a selective YT521-B homology (YTH) domain-containing protein 1 (YTHDC1) inhibitor with an IC50 of 7.4 nM and a KD of 29.6 nM. It can suppress cancer cell proliferation and induce cell G0/G1 phase arrest and apoptosis. YL-5092 can be used for the research of cancer, such as acute myeloid leukemia (AML).

  • Selective YTHDC1 inhibitor with IC50 of 7.4 nM and KD of 29.6 nM.
  • Suppresses cancer cell proliferation.
  • Induces cell G0/G1 phase arrest and apoptosis.
  • Applicable for cancer research, including acute myeloid leukemia (AML).

Catalog No. 50-003-91635 Supplier Medchemexpress LLC Supplier No. HY16460750MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

YL-5092 is a selective YT521-B homology (YTH) domain-containing protein 1 (YTHDC1) inhibitor with an IC50 of 7.4 nM and a KD of 29.6 nM. It can suppress cancer cell proliferation and induce cell G0/G1 phase arrest and apoptosis. YL-5092 can be used for the research of cancer, such as acute myeloid leukemia (AML).

  • Selective YTHDC1 inhibitor with IC50 of 7.4 nM and KD of 29.6 nM.
  • Suppresses cancer cell proliferation.
  • Induces cell G0/G1 phase arrest and apoptosis.
  • Applicable for cancer research, including acute myeloid leukemia (AML).

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.